Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00816959
Recruitment Status : Unknown
Verified July 2011 by American Scitech International.
Recruitment status was:  Not yet recruiting
First Posted : January 6, 2009
Last Update Posted : July 20, 2011
ImClone LLC
Bristol-Myers Squibb
Information provided by:
American Scitech International

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : April 2014
  Estimated Study Completion Date : April 2014